M. Mile

Receptors for luteinizing hormone‐releasing hormone (LHRH) in benign prostatic hyperplasia (BPH) as potential molecular targets for therapy with LHRH antagonist cetrorelix

M. Nadji, A. Schally, N. Block, 2011, The Prostate.

Dose‐dependent growth inhibition in vivo of PC‐3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ‐J‐7‐138

A. Schally, K. Groot, G. Halmos, 2008, The Prostate.